Application Type
Invention
Application SubType
Invention PCT
(10) Registration Number and Date
Status
PUBLISHED/${sta2}
(180) Expiration Date
(20) Filing Number and Date
PH 1/2024/550579 2018.06.08
(40) Publication Number and Date
PH 1/2024/550579
A1
2025.05.05
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
(74) Representative Name
(EN) SyCip Salazar Hernandez & Gatmaitan : 105 Paseo de Roxas St.
(54) Title
(EN) ANTI TRBC1 ANTIGEN BINDING DOMAINS
(57) Abstract
(EN)

The present disclosure relates to anti-TRBCl antigen binding domains characterized by the sequences of the variable chains. The CDRs sequences of the variable chains are : (VH CDR1) GYTFT, (VH CDR2) NPYNDDIQS, (VH CDR3) GAGYNFDGAYRFFDF; and (VL CDR1) RSSQRLVHSNGNTYL, (VL CDR2) RVSNRFP, (VL CDR3) SQSTHVPYT. The claimed humanized antibodies derive from the murine JOVI antibody. Uses in cancer therapy.

(58) Citations
Cited DocumentsReferencesCategoryClaimsCitation Type
1.0WO 2015/132598 A1 (UCL BUSINESS PLC) 11 September 2015 X 1-13Patent
Document Type Date Action
Event NameDateStatus
Filing2018.06.08Filed
PCT National Phase Entry2024.03.05PCT National Phase
Publication2025.05.05PUBLISHED
Publication2025.05.07PUBLISHED